Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nobel Prize Winner appointed to Editorial Board of Journal Nanoteechnology Progress International (JONPI)

Abstract:
Nobel Prize Winner, Professor zur Hausen has accepted to become a member of Honorary Editorial Board to Journal Nanotechnology Progress International (JONPI).

Nobel Prize Winner appointed to Editorial Board of Journal Nanoteechnology Progress International (JONPI)

Ithaca, NY | Posted on December 17th, 2009

Professor zur Hausen is the Nobel Laureates for Medicine 2008 with ground breaking discovery on root causes of cervical cancer. Among others, he is Professor Emeritus of Medicine from Heidelberg University (the oldest German University established in 1386). Professor Zur Hausen is also the Editor-In-Chief of International Journal Cancer among other national and international awards and recognitions.

####

About FONAI
Focus Nanotechnology Africa Inc. (FONAI), is a not-for-profit and tax exempted under Section 501(c) (3) of the IRS code. It is for scientific and educational purpose in the USA, Africa and the Caribbean.

For more information, please click here

Contacts:
Dr. Ejembi John Onah

Copyright © FONAI

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Announcements

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project